Epidemiology Practice Questions

Q: Incidence of a disease is 4 per 1000 of population with duration of 2 years. Calculate the prevalence?

8 per 1000. ***8 per 1000*** - Prevalence can be estimated by multiplying the **incidence rate** by the **duration of the disease**. - In this case, 4/1000 (incidence) * 2 years (duration) = **8 per 1000**. *4 per 1000* - This value represents the **incidence** of the disease, which is the rate of new cases, not the total number of existing cases (prevalence). - Prevalence includes both new and existing cases over a specified period. *2 per 1000* - This value is obtained by dividing the incidence by the duration (4/2), which is not the correct formula for calculating prevalence in this context. - Doing so would incorrectly imply a lower disease burden than what is indicated by the incidence and duration. *6 per 1000* - This option is simply the sum of incidence and duration (4+2), which does not represent a valid epidemiological calculation for prevalence. - Prevalence is determined by considering both the rate of new cases and how long individuals typically live with the disease.

Q: Which measure indicates the diagnostic power of a test to correctly identify those with a disease?

Sensitivity. ***Positive predictive value*** - It refers to the probability that subjects with a positive test result truly have the disease, highlighting the test's **diagnostic accuracy** [1]. - A high positive predictive value indicates that the test is effective at diagnosing the disease in the population tested. *Sensitivity* - Sensitivity measures the ability of a test to correctly identify those with the disease (true positives), but does not account for the test result's predictive capability [1]. - It is important for screening, but **not directly the diagnostic power** for those already tested. *Negative predictive value* - This indicates the probability that subjects with a negative test result truly do not have the disease, focusing on true negatives rather than correct diagnosis of the condition [1]. - While informative, it does not assess the ability to correctly diagnose the disease when the result is positive. *Specificity* - Specificity is the measure of a test's ability to correctly identify those without the disease (true negatives), not diagnosing the disease accurately among those tested [1]. - It is essential for determining false positives but not for assessing the overall diagnostic power of a test. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 253-254.

Q: What is the term used to describe the occurrence of a disease in a susceptible person after they have been in contact with a primary case within the incubation period?

Secondary attack rate. ***Secondary attack rate*** - This term specifically measures the **frequency of new cases** among contacts of primary cases within the incubation period. - It is a key epidemiological measure to assess the **transmissibility** of an infectious agent within a defined population group. - Calculated as: (Number of cases among contacts / Number of susceptible contacts) × 100 *Case fatality rate* - This metric represents the **proportion of deaths** among individuals diagnosed with a specific disease, indicating its severity. - It does not describe the occurrence of disease transmission from a primary case to susceptible contacts. *Primary attack rate* - This refers to the **number of cases occurring among the total population at risk** during the initial period of an outbreak. - It differs from secondary attack rate, which specifically measures transmission from a **known primary case to their contacts**. - Primary attack rate does not distinguish between primary and secondary cases. *Tertiary attack rate* - This term is not a commonly used or recognized epidemiological measure. - While disease transmission can occur beyond secondary contacts, there isn't a standard "tertiary attack rate" used in epidemiological practice.

Q: What is the primary ecological unit of study in epidemiology for understanding disease patterns and public health?

Population. ***Population*** - In public health and epidemiology, a **population** is the fundamental unit for studying disease patterns, incidence, prevalence, and risk factors across groups. - Understanding disease at the population level allows for the development of **prevention strategies**, public health interventions, and policy making that impact many individuals. *Individual patient* - While critical for clinical diagnosis and treatment, the **individual patient** represents a single case and does not provide insights into broader disease patterns or public health trends. - Studying individuals primarily informs **patient management** and understanding disease pathophysiology rather than population-level epidemiology. *Community* - A **community** is a group of people living in the same place or having a particular characteristic in common, which is a broader concept than a population. - While public health interventions often target communities, the underlying data and epidemiological analyses are typically based on defined **populations within** or across communities. *Case study* - A **case study** is an in-depth analysis of a single individual, group, or event, offering rich, detailed information. - While valuable for generating hypotheses or understanding rare conditions, a case study does not provide the **statistical power** or generalizability needed to understand disease patterns across large groups.

Q: Which of the following is considered the weakest criterion in the causal relationship hypothesis?

Specificity of association (one-to-one relationship). ***Specificity of association (one-to-one relationship)*** - While a specific, one-to-one relationship between cause and effect (e.g., one exposure leading to only one disease) **might seem intuitive**, it is often not observed in complex biological systems. - Many diseases have **multiple causes** (e.g., lung cancer can be caused by smoking, asbestos, radon), and many exposures can lead to **multiple effects** (e.g., smoking causes lung cancer, heart disease, COPD). Therefore, requiring specificity as a strong criterion significantly limits its applicability and validity in establishing causality. *Temporal relationship (cause precedes effect)* - This is a **necessary criterion** for causality, meaning the cause must always occur before the effect. - Without a correct temporal sequence, it is **impossible to establish a causal link**, as an effect cannot precede its cause. *Biological gradient (increased exposure leads to increased effect)* - A **dose-response relationship** suggests that as the exposure level increases, the risk or severity of the outcome also increases. - This criterion provides strong evidence for causality because it indicates a **direct biological mechanism** linking the exposure to the effect. *Strength of association (stronger relationships are more reliable)* - A **strong statistical association** (e.g., a high relative risk or odds ratio) makes it less likely that the observed relationship is due to confounding factors. - While not solely sufficient, a strong association is a **powerful indicator** that a causal link may exist.

Q: How often is the Sample Registration System conducted in India?

1 year. ***1 year*** - The **Sample Registration System (SRS)** in India is a large-scale demographic survey conducted **annually** to provide reliable estimates of birth rates, death rates, and other fertility and mortality indicators. - Its annual nature allows for regular monitoring of demographic changes and health trends across different states and regions. *6 months* - While some surveys or data collections might occur semi-annually, the comprehensive SRS is not conducted every six months. - Conducting a system as extensive as the SRS twice a year would be logistically challenging and resource-intensive. *2 years* - A biennial (every two years) frequency would mean less up-to-date data for tracking rapid demographic shifts or evaluating the immediate impact of health interventions. - The need for current statistics on vital events necessitates a more frequent survey than every two years. *5 years* - A quinquennial (every five years) frequency would provide very infrequent data, which is insufficient for effective public health planning and policy formulation. - Key demographic indicators are needed more regularly than every five years to respond to evolving health and population needs.

Q: What is the primary benefit of screening for diseases?

Early detection of diseases. ***Early detection of diseases*** - This is the **primary benefit** and defining purpose of **screening programs** in public health. - Screening identifies diseases in their **presymptomatic or early stage** when individuals are apparently healthy, allowing for intervention before clinical symptoms appear. - According to epidemiological principles, the goal of screening is to detect disease **earlier than it would be found through routine clinical practice**. - Early detection enables better prognosis through **lead time** and **length time bias** advantages. *Timely treatment of identified conditions* - While treatment is the **ultimate goal** of healthcare, it is not specific to screening—treatment occurs whether disease is found through screening or clinical presentation. - Treatment is the **consequence** of early detection, not the primary benefit of the screening process itself. - The unique value of screening lies in **detection**, not treatment per se. *Providing support for patients after diagnosis* - **Patient support** is an important aspect of healthcare but is not the purpose of screening programs. - This is **post-diagnostic care**, which follows after the screening process has identified cases. *Identifying all potential cases of a disease* - **Screening tests** cannot identify all cases due to inherent limitations in **sensitivity** and **specificity**. - Screening aims to identify a significant proportion of cases in a population, accepting that some will be missed (**false negatives**) and some healthy individuals may test positive (**false positives**).

Q: Which of the following is an example of a case-control study?

PVC exposure and angiosarcoma of the liver. ***PVC exposure and angiosarcoma of the liver*** - This is a classic example of a **case-control study** where individuals with a rare disease (angiosarcoma of the liver) are identified (cases) and compared to a control group without the disease to determine past exposures (PVC). - The study looked back in time to identify differences in exposure between cases and controls. *Framingham heart study (cohort study)* - The Framingham Heart Study is a well-known **prospective cohort study** that has followed participants over time to observe the development of cardiovascular disease. - In a cohort study, researchers identify a group of individuals and follow them forward in time to see who develops the outcome of interest, making it different from a case-control design. *Doll & Hill Study (cohort study)* - The Doll & Hill study is a landmark **cohort study** that investigated the association between smoking and lung cancer by following a group of British doctors over several years. - This study started with healthy individuals and observed them over time to see who developed lung cancer, which is characteristic of a cohort design. *Thalidomide exposure and its association with teratogenicity* - While the thalidomide tragedy led to crucial epidemiological investigations, the initial identification of the association was often through **case series** or **descriptive epidemiology**, noting an unusual clustering of rare birth defects among infants whose mothers took thalidomide. - Subsequent studies might have incorporated case-control elements, but the prompt asks for an example of a case-control study, and this event itself is generally cited for its role in pharmacovigilance and observational studies rather than a single, classic case-control study example in the way "PVC and angiosarcoma" is.

Q: Most commonly used blinding technique in epidemiological studies?

Double blinding. ***Double blinding*** - In **double blinding**, neither the **participants** nor the **researchers** administering the intervention and collecting data know who is in the treatment group versus the control group. - This method is widely used to prevent **observer bias** from the researchers and **participant bias** (e.g., placebo effect) from the subjects, thereby strengthening the study's internal validity. *Single blinding* - In **single blinding**, only the **participants** are unaware of their assignment to either the treatment or control group. - While it helps reduce participant bias, the **researchers' knowledge** of group assignments can still introduce **observer bias**, making it less rigorous than double blinding. *Triple blinding* - **Triple blinding** extends double blinding by ensuring that the **data analysts** are also unaware of the participant group assignments. - This technique further minimizes bias in the **interpretation and analysis of results**, but it is less commonly implemented due to its complexity and increased logistical challenges compared to double blinding. *None of the options* - This option is incorrect because **blinding techniques** are fundamental tools in epidemiological studies and clinical trials to ensure the objectivity and reliability of research findings. - **Blinding** helps eliminate conscious and unconscious biases that could otherwise influence study outcomes.

Question 1

In a screening test for DM out of 1000 population, 90 were positive. When the gold standard test was applied to the entire population, 100 were found to have the disease. Assuming all 90 screening positives were confirmed as true positives by the gold standard, calculate the sensitivity.

Accepted Answer

True positives divided by total actual positives (90%)

Answer

All positives identified by the test assumed as true positives (100%)

Answer

Underestimated true positives divided by total actual positives (80%)

Answer

Total positives identified by the test divided by total actual positives (90%)

Question 2

Incidence of a disease is 4 per 1000 of population with duration of 2 years. Calculate the prevalence?

Accepted Answer

8 per 1000

Answer

4 per 1000

Answer

2 per 1000

Answer

6 per 1000

Question 3

Which measure indicates the diagnostic power of a test to correctly identify those with a disease?

Accepted Answer

Sensitivity

Answer

Negative predictive value

Answer

Specificity

Answer

Positive predictive value

Question 4

What is the term used to describe the occurrence of a disease in a susceptible person after they have been in contact with a primary case within the incubation period?

Accepted Answer

Secondary attack rate

Answer

Case fatality rate

Answer

Primary attack rate

Answer

Tertiary attack rate

Question 5

What is the primary ecological unit of study in epidemiology for understanding disease patterns and public health?

Accepted Answer

Population

Answer

Community

Answer

Individual patient

Answer

Case study

Question 6

Which of the following is considered the weakest criterion in the causal relationship hypothesis?

Accepted Answer

Specificity of association (one-to-one relationship)

Answer

Temporal relationship (cause precedes effect)

Answer

Biological gradient (increased exposure leads to increased effect)

Answer

Strength of association (stronger relationships are more reliable)

Question 7

How often is the Sample Registration System conducted in India?

Accepted Answer

1 year

Answer

2 years

Answer

5 years

Answer

6 months

Question 8

What is the primary benefit of screening for diseases?

Accepted Answer

Early detection of diseases

Answer

Providing support for patients after diagnosis

Answer

Identifying all potential cases of a disease

Answer

Timely treatment of identified conditions

Question 9

Which of the following is an example of a case-control study?

Accepted Answer

PVC exposure and angiosarcoma of the liver

Answer

Framingham heart study

Answer

Doll & Hill Study

Answer

Thalidomide exposure and its association with teratogenicity

Question 10

Most commonly used blinding technique in epidemiological studies?

Accepted Answer

Double blinding

Answer

None of the options

Answer

Single blinding

Answer

Triple blinding

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?